Skip to main content
. Author manuscript; available in PMC: 2010 Aug 17.
Published in final edited form as: J Neurochem. 2004 Dec;91(5):1057–1066. doi: 10.1111/j.1471-4159.2004.02792.x

Table 2.

History of medication of subjects included in the study

Subject Drugs
RRa,b Amlodipine, Ranitidine
VVa,b Digoxin, dipyridamole
FF1a,b None
HH1a,b Clonazapam, Nicardipine, Dijoxin, Metaprolol, Prednisone, Simvastatin, Torsemide, Glipizide, Lisinopril, Ranitidine
BB1a,b None
KS6a,b None
KS18a None
KS21a,b None
KS23a,b Digoxin
KS27a,b Propranolol, Chlorthalidone
IIa,b Captopril, Endurolyl, Enalapril maleate, Topral, Lopressor
KKa,b Glyburide, Methylprednisolone, Propoxyphene
TTa,b Elmiron, Lorazepam, Citalopram, Paroxetine
WWa,b Unknown
GG1a,b Unknown
JJ1a,b Sertaline
DD1a,b Sumatriptan, Loracarbef
KS8a,b Paxil, Trazedone, Xanax, Accupro, Hydrochlorothiazide
KS17a None
KS12a,b None
KS24a,b Lisinopril, Potassium, Spironolactone
KS28a,b Sertaline, Prednisone
JJa,b Alprazolam, Risperidone, Amoxicillin, Valproic Acid, Nitrofurintoin
MMa,b Flomax, Etodolac, Ranitidine, Terazosin

Subjects used in

a

locus coeruleus and

b

cerebellum study.